• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Datavault AI Announces Update Regarding Distribution of Dream Bowl 2026 Meme Coin

    11/21/25 3:56:48 PM ET
    $DVLT
    $SCLX
    Semiconductors
    Technology
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $DVLT alert in real time by email

    PHILADELPHIA, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real‑world asset tokenization technologies, announced today that, in connection with its previously announced distribution of Dream Bowl 2026 Meme Coins to eligible record equity holders of Datavault AI, Nasdaq has informed the Company that it is not expecting to quote an ex-dividend date for such distribution and therefore eligible record equity holders of Datavault AI must be holders as of the record date of November 25, 2025 in order to receive the distribution. 

    With respect to Datavault AI's voluntary distribution of Dream Bowl 2026 Meme Coins to record holders of common stock of Scilex Holding Company (NASDAQ:SCLX), given that such distribution is being made as a token of Datavault AI's appreciation for Scilex's relationship with Datavault AI as a stockholder of Datavault AI, licensing partner and co-sponsor of the Dream Bowl XIV event to be held on January 11, 2026, Nasdaq has informed the Company that it is not planning to make any announcement regarding such distribution for Scilex, whether as to the record date or an ex-dividend date.  Notwithstanding the absence of such announcement, Datavault AI intends to make such voluntary distribution to record holders of Scilex common stock as of November 25, 2025 concurrently with the distribution of the Dream Bowl 2026 Meme Coins to Datavault AI's eligible record equity holders. 

    The Dream Bowl 2026 Meme Coins will be airdropped to Data Vault® wallets following the payment date for the distribution, subject to recipient's electing to opt-in to the distribution and setting up a digital wallet with Datavault AI and providing Datavault AI with documentation confirming same.  Subject to the right of the Board of Directors of Datavault AI to change the record date, the payment date for this distribution will be determined by subsequent resolutions of the Board of Directors of Datavault AI, which will be within 60 days following the record date.

    The record date for the distribution may be changed by the Board of Directors of Datavault AI for any reason at any time prior to the actual payment date, and payment of the distribution is conditioned upon the Board not having revoked the distribution prior to the payment date, including for a material change to the solvency or surplus analysis presented to the Board of Directors of Datavault AI. 

    The Company will provide further instructions regarding wallet setup, token access, and distribution procedures in a subsequent communication prior to the payment date.

    About Datavault AI

    Datavault AITM (NASDAQ:DVLT) is leading the way in AI driven data experiences, valuation and monetization of assets in the Web 3.0 environment. The Company's cloud-based platform provides comprehensive solutions with a collaborative focus in its Acoustic Science and Data Science Divisions. Datavault AI's Acoustic Science Division features WiSA®, ADIO® and Sumerian® patented technologies and industry-first foundational spatial and multichannel wireless HD sound transmission technologies with IP covering audio timing, synchronization and multi-channel interference cancellation. The Data Science Division leverages the power of Web 3.0 and high-performance computing to provide solutions for experiential data perception, valuation and secure monetization. Datavault AI's cloud-based platform provides comprehensive solutions serving multiple industries, including HPC software licensing for sports & entertainment, events & venues, biotech, education, fintech, real estate, healthcare, energy and more. The Information Data Exchange® (IDE) enables Digital Twins, licensing of name, image and likeness (NIL) by securely attaching physical real-world objects to immutable metadata objects, fostering responsible AI with integrity. Datavault AI's technology suite is completely customizable and offers AI and Machine Learning (ML) automation, third-party integration, detailed analytics and data, marketing automation and advertising monitoring. The Company is headquartered in Philadelphia, PA. Learn more about Datavault AI at www.dvlt.ai.

    Forward-Looking Statements

    This press release contains "forward-looking statements" (within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, and other securities laws) about Datavault AI Inc. ("Datavault AI," the "Company," "us," "our," or "we") and our industry that involve risks and uncertainties.  In some cases, you can identify forward-looking statements because they contain words, such as "may," "might," "will," "shall," "should," "expects," "plans," "anticipates," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential," "goal," "objective," "seeks," "likely" or "continue" or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions. The absence of these words does not mean that a statement is not forward-looking. Such forward-looking statements, including, but not limited to, statements regarding future events, Datavault AI's potential distribution of the Dream Bowl 2026 Meme Coin and the timing thereof (including that the Board of Directors of Datavault AI may change the record date and, as a result, the payment date thereof), are necessarily based upon estimates and assumptions that, while considered reasonable by the Company and its management, are inherently uncertain. Readers are cautioned not to place undue reliance on these and other forward-looking statements contained herein.

    Actual results may differ materially from those indicated by these forward-looking statements as a result of various risks and uncertainties including, but not limited to, the following: risks related to legal proceedings that may be instituted against the parties regarding the Dream Bowl 2026 Meme Coin and the distribution thereof to Datavault AI's eligible equity holders and/or Scilex holders of common stock; risks associated with the right of the Board of Directors of Datavault AI to change the record date (and therefore the payment date) of the distribution of, and/or to revoke, the Dream Bowl 2026 Meme Coin; changes in economic, market, or regulatory conditions; uncertainties regarding valuation methodologies and third-party reports; risks relating to evolving regulatory frameworks applicable to tokenized assets; risks associated with technological development and integration; and other risks and uncertainties as more fully described in Datavault AI's filings with the U.S. Securities and Exchange Commission (the "SEC"), including its Annual Report on Form 10-K for the year ended December 31, 2024 and other filings that Datavault AI makes from time to time with the SEC, which are available on the SEC's website at www.sec.gov, and could cause actual results to vary from expectations.

    The forward-looking statements made in this press release relate only to events as of the date on which the statements are made. Datavault AI undertakes no obligation to update any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law. Datavault AI may not actually achieve the plans, intentions or expectations disclosed in its forward-looking statements, and you should not place undue reliance on such forward-looking statements. Datavault AI's forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments it may make.

    Investor Contact:

    800.491.9665

    Media Inquiries:

    marketing@dvlt.ai

    Corporate Communications:



    IBN

    Austin, Texas

    www.InvestorBrandNetwork.com

    512.354.7000 Office

    Editor@InvestorBrandNetwork.com



    Primary Logo

    Get the next $DVLT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DVLT
    $SCLX

    CompanyDatePrice TargetRatingAnalyst
    Scilex Holding Company
    $SCLX
    1/27/2025$22.00Buy
    D. Boral Capital
    Scilex Holding Company
    $SCLX
    10/16/2024$14.00Buy
    Alliance Global Partners
    Scilex Holding Company
    $SCLX
    6/13/2024$13.00Buy
    Rodman & Renshaw
    Scilex Holding Company
    $SCLX
    10/16/2023$4.00Buy
    B. Riley Securities
    Scilex Holding Company
    $SCLX
    10/13/2023$4.00Buy
    B. Riley Securities
    Scilex Holding Company
    $SCLX
    10/9/2023$12.00Buy
    H.C. Wainwright
    More analyst ratings

    $DVLT
    $SCLX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Scilex Holding Company ("Scilex") Announces a Payment Date of June 15, 2026 for the Previously Announced Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities

    PALO ALTO, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (NASDAQ:SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that its board of directors (the "Board") has set June 15, 2026 as the payment date (the "Payment Date") for the previously announced dividend of Semnur Pharmaceuticals, Inc. ("Semnur") (OTC:SMNR) common stock held by the Company to its stockholders and certain other eligible holders of Scilex securities (collectively, the "Participati

    6/4/26 9:00:00 AM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Perpetuals Reports $4.5 Billion in UpsideOnly Volume and Signs Exchange Agreement With Datavault AI for Tokenized Commodities

    UpsideOnly draws more than 30,000 active users from 185 countries in its first two weeks Perpetuals signs exchange agreement with Datavault AI, bringing tokenized gold, copper, geothermal energy, and critical minerals to 24/7 regulated global trading Perpetuals.com Ltd (NASDAQ:PDC) today reported strong early results for its breakout UpsideOnly trading and market prediction platform and announced an agreement with Datavault AI Inc. (NASDAQ:DVLT) to list tokenized real-world commodity assets on the Perpetuals platform. In its first two weeks, traders flocked to the UpsideOnly platform, attracting more than 30,000 active users, generating $4.5 billion in cumulative platform volume ac

    6/2/26 8:00:00 AM ET
    $DVLT
    $PDC
    Semiconductors
    Technology
    EDP Services

    Datavault AI Signs $2.0 Billion Structured Financing Term Sheet With Exclusive Global Tokenization Mandate

    Counterparty agrees to route its global digital asset tokenization and blockchain infrastructure initiatives exclusively through Datavault AI's patented platform. Financing is anchored by an approximately $2.0 billion portfolio of fixed income securities contributed by an institutional investment fund and a UK-based regulated structured institutional investment platform. The proposed transaction is expected to value Datavault AI shares at $1.55 to $2.00 per share, subject to definitive agreements and an acceptable independent valuation. Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real-wo

    6/1/26 2:55:00 AM ET
    $DVLT
    Semiconductors
    Technology

    $DVLT
    $SCLX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Vivasor, Inc. sold $11,253,832 worth of shares (20,000,000 units at $0.56), decreasing direct ownership by 26% to 55,942,666 units (SEC Form 4)

    4 - Datavault AI Inc. (0001682149) (Issuer)

    6/2/26 8:40:30 PM ET
    $DVLT
    Semiconductors
    Technology

    New insider Vivasor, Inc. claimed ownership of 75,942,666 shares (SEC Form 3)

    3 - Datavault AI Inc. (0001682149) (Issuer)

    6/2/26 8:39:16 PM ET
    $DVLT
    Semiconductors
    Technology

    Amendment: Chief Executive Officer Bradley Nathaniel T was granted 3,801,471 shares, increasing direct ownership by 31% to 10,906,188 units (SEC Form 4)

    4/A - Datavault AI Inc. (0001682149) (Issuer)

    5/14/26 4:01:17 PM ET
    $DVLT
    Semiconductors
    Technology

    $DVLT
    $SCLX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Shah Jaisim bought $13,800 worth of shares (30,000 units at $0.46), increasing direct ownership by 27% to 139,333 units (SEC Form 4)

    4 - Scilex Holding Co (0001820190) (Issuer)

    12/18/24 7:04:41 PM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Executive Chairperson Ji Henry bought $8,351 worth of shares (8,888 units at $0.94), increasing direct ownership by 3% to 320,161 units (SEC Form 4)

    4 - Scilex Holding Co (0001820190) (Issuer)

    10/31/24 12:44:57 PM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Officer Shah Jaisim bought $31,670 worth of shares (32,000 units at $0.99), increasing direct ownership by 41% to 109,333 units (SEC Form 4)

    4 - Scilex Holding Co (0001820190) (Issuer)

    10/29/24 6:59:31 PM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $DVLT
    $SCLX
    SEC Filings

    View All

    Datavault AI Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Datavault AI Inc. (0001682149) (Filer)

    6/4/26 5:06:35 PM ET
    $DVLT
    Semiconductors
    Technology

    SEC Form S-3 filed by Scilex Holding Company

    S-3 - Scilex Holding Co (0001820190) (Filer)

    6/2/26 5:09:14 PM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form EFFECT filed by Scilex Holding Company

    EFFECT - Scilex Holding Co (0001820190) (Filer)

    5/26/26 12:15:13 AM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $DVLT
    $SCLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    D. Boral Capital initiated coverage on Scilex Holding with a new price target

    D. Boral Capital initiated coverage of Scilex Holding with a rating of Buy and set a new price target of $22.00

    1/27/25 8:08:33 AM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Alliance Global Partners initiated coverage on Scilex Holding with a new price target

    Alliance Global Partners initiated coverage of Scilex Holding with a rating of Buy and set a new price target of $14.00

    10/16/24 8:01:57 AM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Rodman & Renshaw initiated coverage on Scilex Holding with a new price target

    Rodman & Renshaw initiated coverage of Scilex Holding with a rating of Buy and set a new price target of $13.00

    6/13/24 7:16:15 AM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $DVLT
    $SCLX
    Financials

    Live finance-specific insights

    View All

    Scilex Holding Company ("Scilex") Announces a Payment Date of June 15, 2026 for the Previously Announced Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities

    PALO ALTO, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (NASDAQ:SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that its board of directors (the "Board") has set June 15, 2026 as the payment date (the "Payment Date") for the previously announced dividend of Semnur Pharmaceuticals, Inc. ("Semnur") (OTC:SMNR) common stock held by the Company to its stockholders and certain other eligible holders of Scilex securities (collectively, the "Participati

    6/4/26 9:00:00 AM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Scilex Holding Company ("Scilex") Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026

    PALO ALTO, Calif., May 22, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (NASDAQ:SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that its board of directors (the "Board") approved a dividend of Semnur Pharmaceuticals, Inc. ("Semnur") (OTC:SMNR) common stock held by the Company to its stockholders and certain other eligible equityholders of Scilex (collectively, the "Participating Holders"). The record date for the dividend is June 1, 2026 (the "Record Date"). Th

    5/22/26 1:15:00 PM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Datavault AI Announces Board of Directors Has Requested Management's Complete Plan for Dividend Spin-Out of Acoustic Sciences Division into Stand-Alone Public Company

    Initial planning calls for Data Sciences Division to focus efforts in cyber secure infrastructure with dedication in fintech and patented Information Data Exchange® (IDE®) Management will harness its API Media acquisition, robust patent portfolio, ADIO® Inaudible Tones, WiSA® and Dolby® partnerships to establish worldwide acoustic industry standards in high-definition wireless transmission, spatial-audio control and interoperability Plan includes API media's stand-alone and renewed execution of WiSA semiconductor and software modules strategy with an R&D effort targeted to new robotic and drone applications Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a pioneerin

    5/7/26 9:07:00 AM ET
    $DVLT
    Semiconductors
    Technology

    $DVLT
    $SCLX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by Scilex Holding Company (Amendment)

    SC 13D/A - Scilex Holding Co (0001820190) (Subject)

    4/25/24 5:25:28 PM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13D/A filed by Scilex Holding Company (Amendment)

    SC 13D/A - Scilex Holding Co (0001820190) (Subject)

    3/5/24 4:22:28 PM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $DVLT
    $SCLX
    Leadership Updates

    Live Leadership Updates

    View All

    Scilex Holding Company Appoints Kasowitz LLP as Litigation and Intellectual Property Counsel

    PALO ALTO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (NASDAQ:SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, announced that it has appointed Kasowitz LLP and its founding partner Marc Kasowitz as the Company's litigation and intellectual property counsel. Kasowitz LLP will advise Scilex on complex commercial litigation, patent litigation, intellectual property enforcement and defense, licensing matters, and strategic intellectual property governance as the C

    1/2/26 9:00:00 AM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Datavault AI Appoints U.S. Navy Veteran Pete Scobell as Vice President, Global Security

    BEAVERTON, Ore., Oct. 21, 2025 (GLOBE NEWSWIRE) -- via IBN -- Datavault AI Inc. (NASDAQ:DVLT), leading the way in AI data experience, valuation, and monetization, today announced the appointment of Pete Scobell as Vice President, Global Security. A decorated U.S. Navy SEAL veteran, Scobell will oversee Datavault AI's global security operations, risk management, and the execution of real-world asset logistics activity across all regions. Scobell's appointment comes as Datavault AI continues to advance its Anti-Stolen Valor initiative, first announced earlier this year, honoring military service, integrity, and accountability through a values-driven, data-backed ecosystem. The program reinf

    10/21/25 6:05:00 AM ET
    $DVLT
    Semiconductors
    Technology

    Datavault AI Updates 4th Quarter, 2025 Outlook

    ·Company Incorporates Four Innovative Independent Data Exchanges with Expected Q4-25 Revenue Contribution ·Exchanges Expected to be Bolstered by Foundational Patents in the Tokenomics Economy ·Begins Enforcement Initiative with Top Tier Banks Led by Leading IP Firm BEAVERTON, Ore., Oct. 06, 2025 (GLOBE NEWSWIRE) -- via IBN – Datavault AI Inc. (NASDAQ:DVLT), a pioneer in AI-driven tokenization and data monetization, today updated its 4th quarter of 2025 outlook and 2026 revenue guidance.  Highlights of the Company's Q4-25 outlook includes: ·Incorporating four innovative independent data exchanges ·Enhancing its patent portfolio, now exceeding 70 patents/filings, focused on c

    10/6/25 6:00:00 AM ET
    $DVLT
    Semiconductors
    Technology